Neuland Laboratories Ltd (NEULANDLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 229993, "name": "Neuland Labs.", "stock_name": "Neuland Labs.", "full_name": "Neuland Laboratories Ltd", "name_url": "stocks-analysis/neuland-labs", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "13,036.15", "chg": -164.15, "chgp": "-1.24%", "dir": -1, "prev_price": "13,200.30", "mcapval": "16,871.00 Cr", "mcap": "Small Cap", "scripcode": 524558, "symbol": "NEULANDLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE794A01010", "curr_date": "Feb 06", "curr_time": "", "bse_nse_vol": "18.23 k", "exc_status": "Active", "traded_date": "Feb 06, 2026", "traded_date_str": "2026 02 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Neuland Laboratories Declines 1.56% Despite Hold Upgrade: 5 Key Factors Shaping the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-declines-156-despite-hold-upgrade-5-key-factors-shaping-the-week-3827412", "imagepath": "", "date": "2026-02-08 12:01:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Rating upgraded to Hold as technicals improve and financials strengthen</p>\n <p><strong>3 Feb:</strong> Significant gap up opening, outperforming Sensex and sector</p>\n <p><strong>3 Feb:</strong> Technical momentum shifts amid mixed market signals</p>\n <p><strong>5 Feb:</strong> Technical trend moves from mildly bearish to sideways consolidation</p>\n <p><strong>6 Feb:</strong> Mildly bearish technical shift amid mixed momentum; week closes lower</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</d..." }, { "title": "Neuland Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-faces-mildly-bearish-technical-shift-amid-mixed-momentum-3823519", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_technicaldot_3823519.png", "date": "2026-02-06 08:00:30", "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite a recent downgrade in its technical outlook, the stock’s daily moving averages suggest some underlying bullishness, presenting a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3821535", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_technicaldot_3821535.png", "date": "2026-02-05 08:00:35", "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day change of 0.11%, the stock’s recent performance and technical signals suggest a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Neuland Laboratories Ltd Opens Strong with Significant Gap Up on 3 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3817545", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_gapup_3817545.png", "date": "2026-02-03 09:36:13", "description": "Neuland Laboratories Ltd commenced trading on 03 Feb 2026 with a significant gap up, opening 5.12% higher than its previous close. This robust start outpaced the Pharmaceuticals & Biotechnology sector's gain of 2.66%, signalling a positive market response to recent developments surrounding the stock." }, { "title": "Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3817085", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_technicaldot_3817085.png", "date": "2026-02-03 08:00:47", "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from a sideways trend to a mildly bearish stance. Despite a recent downgrade in price and a day change of -3.21%, the stock’s longer-term fundamentals remain robust, though near-term caution is advised given the mixed technical signals." }, { "title": "Neuland Laboratories Upgraded to Hold as Technicals Improve and Financials Strengthen", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-upgraded-to-hold-as-technicals-improve-and-financials-strengthen-3815677", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_mojoScore_3815677.png", "date": "2026-02-02 08:10:46", "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook and recent financial results. The upgrade, effective from 1 February 2026, is underpinned by a stabilising technical trend, robust quarterly earnings growth, and a solid institutional investor base, despite lingering concerns over valuation and long-term sales growth." }, { "title": "Why is Neuland Laboratories Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-neuland-laboratories-ltd-fallingrising-3815103", "imagepath": "", "date": "2026-02-02 00:47:42", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Neuland Laboratories has outperformed its sector and the broader market in the short term. Over the past week, the stock gained 2.52%, contrasting with the Sensex's 1.00% decline during the same period. This positive momentum is further underscored by the stock’s consecutive gains over the last two days, delivering an 8.17% return in that timeframe. On 01-Feb, the stock reached an intraday high of ₹14,009.05, marking a 5.79% increase from previous levels. Such intraday strength indicates strong buying interest and optimism among investors.</p>\n<p>Despite this recent surge, the stock’s longer-term performance reveals some headwinds. Over the past month and year-to-date, Neuland Laboratories has declined by 9.22% and 10.62% respectively,..." }, { "title": "Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3813528", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_technicaldot_3813528.png", "date": "2026-02-01 08:00:44", "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of technical indicators. Despite a 5.16% rise in the stock price to ₹13,200 on 1 Feb 2026, the overall technical signals remain mixed, prompting a downgrade in its Mojo Grade from Hold to Sell as of 27 Jan 2026." }, { "title": "Neuland Laboratories Downgraded to Sell Amid Valuation and Growth Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-downgraded-to-sell-amid-valuation-and-growth-concerns-3806771", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NeulandLaborato_mojoScore_3806771.png", "date": "2026-01-28 08:05:36", "description": "Neuland Laboratories Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 27 Jan 2026, reflecting concerns over its valuation, financial trends, and long-term growth prospects despite recent quarterly improvements. The pharmaceutical company’s current Mojo Score stands at 48.0, signalling caution for investors amid underperformance relative to the broader market." } ], "total": 728, "sid": "229993", "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "04-Feb-2026", "details": "Intimation about Schedule of Analyst / Institutional Investor Meeting on February 11 2026", "source": "BSE" }, { "caption": "Intimation Regarding Conversion Of Statutory AuditorS Firm To A Limited Liability Partnership (LLP)", "datetime": "30-Jan-2026", "details": "Intimation regarding conversion of Statutory Auditors Firm to a LLP", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "27-Jan-2026", "details": "Q3FY26 Earnings Call Intimation", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "09 Feb 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has declared <strong>120%</strong> dividend, ex-date: 18 Jul 25", "dt": "2025-07-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14", "dt": "2014-08-13", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

2 Feb: Rating upgraded to Hold as technicals improve and financials strengthen

3 Feb: Significant gap up opening, outperforming Sensex and sector

3 Feb: Technical momentum shifts amid mixed market signals

5 Feb: Technical trend moves from mildly bearish to sideways consolidation

6 Feb: Mildly bearish technical shift amid mixed momentum; week closes lower

Week OpenRead full news article

Neuland Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum

2026-02-06 08:00:30

Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite a recent downgrade in its technical outlook, the stock’s daily moving averages suggest some underlying bullishness, presenting a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-05 08:00:35

Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day change of 0.11%, the stock’s recent performance and technical signals suggest a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Neuland Laboratories Ltd Opens Strong with Significant Gap Up on 3 Feb 2026

2026-02-03 09:36:13

Neuland Laboratories Ltd commenced trading on 03 Feb 2026 with a significant gap up, opening 5.12% higher than its previous close. This robust start outpaced the Pharmaceuticals & Biotechnology sector's gain of 2.66%, signalling a positive market response to recent developments surrounding the stock.

Read full news article

Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-03 08:00:47

Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from a sideways trend to a mildly bearish stance. Despite a recent downgrade in price and a day change of -3.21%, the stock’s longer-term fundamentals remain robust, though near-term caution is advised given the mixed technical signals.

Read full news article

Neuland Laboratories Upgraded to Hold as Technicals Improve and Financials Strengthen

2026-02-02 08:10:46

Neuland Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook and recent financial results. The upgrade, effective from 1 February 2026, is underpinned by a stabilising technical trend, robust quarterly earnings growth, and a solid institutional investor base, despite lingering concerns over valuation and long-term sales growth.

Read full news article

Why is Neuland Laboratories Ltd falling/rising?

2026-02-02 00:47:42

Recent Price Movement and Market Context

Neuland Laboratories has outperformed its sector and the broader market in the short term. Over the past week, the stock gained 2.52%, contrasting with the Sensex's 1.00% decline during the same period. This positive momentum is further underscored by the stock’s consecutive gains over the last two days, delivering an 8.17% return in that timeframe. On 01-Feb, the stock reached an intraday high of ₹14,009.05, marking a 5.79% increase from previous levels. Such intraday strength indicates strong buying interest and optimism among investors.

Despite this recent surge, the stock’s longer-term performance reveals some headwinds. Over the past month and year-to-date, Neuland Laboratories has declined by 9.22% and 10.62% respectively,...

Read full news article

Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-01 08:00:44

Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of technical indicators. Despite a 5.16% rise in the stock price to ₹13,200 on 1 Feb 2026, the overall technical signals remain mixed, prompting a downgrade in its Mojo Grade from Hold to Sell as of 27 Jan 2026.

Read full news article

Neuland Laboratories Downgraded to Sell Amid Valuation and Growth Concerns

2026-01-28 08:05:36

Neuland Laboratories Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 27 Jan 2026, reflecting concerns over its valuation, financial trends, and long-term growth prospects despite recent quarterly improvements. The pharmaceutical company’s current Mojo Score stands at 48.0, signalling caution for investors amid underperformance relative to the broader market.

Read full news article

View All News